Predictive Factors in Metastatic Breast Cancer
Author Information
Author(s): E Niskanen, C Blomqvist, K Franssila, P Hietanen, V-M Wasenius
Primary Institution: University of Helsinki
Hypothesis
What is the predictive value of histological and molecular abnormalities in the primary tumor for treatment outcomes in metastatic breast cancer patients?
Conclusion
Histological grade is the most powerful predictor of chemotherapy response in metastatic breast cancer, while c-erbB-2, p53, and cathepsin-D do not predict treatment outcomes.
Supporting Evidence
- Histological grade was the best predictor of chemotherapy response.
- Patients with grade 1 tumors had the longest time to progression.
- C-erbB-2, p53, and cathepsin-D did not predict treatment outcomes.
- Median follow-up time ranged from 15 to 101 months.
Takeaway
Doctors looked at different factors in breast cancer tumors to see if they could predict how well patients would respond to treatment. They found that the type of tumor was the best clue.
Methodology
The study analyzed histological and molecular characteristics of tumors from 127 patients with metastatic breast cancer who received FEC chemotherapy.
Limitations
The study only included patients who had developed metastatic disease after removal of the primary tumor, which may limit the generalizability of the findings.
Participant Demographics
{"median_age":54,"menopausal_status":{"premenopausal":55,"postmenopausal":45,"unknown":3},"ER_status":{"positive":60,"negative":36},"PR_status":{"positive":60,"negative":36}}
Statistical Information
P-Value
p<0.0005
Statistical Significance
p<0.0005
Want to read the original?
Access the complete publication on the publisher's website